ENLIE Pharmaceutical JSC (HSTC:BCP) Change In Receivables : ₫0.00 Mil (TTM As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is ENLIE Pharmaceutical JSC Change In Receivables?

ENLIE Pharmaceutical JSC's change in receivables for the quarter that ended in . 20 was ₫0.00 Mil. It means ENLIE Pharmaceutical JSC's Accounts Receivable stayed the same from . 20 to . 20 .

ENLIE Pharmaceutical JSC's change in receivables for the fiscal year that ended in . 20 was ₫0.00 Mil. It means ENLIE Pharmaceutical JSC's Accounts Receivable stayed the same from . 20 to . 20 .

ENLIE Pharmaceutical JSC's Accounts Receivable for the quarter that ended in . 20 was ₫0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. ENLIE Pharmaceutical JSC's liquidation value for the six months ended in . 20 was ₫0.00 Mil.

ENLIE Pharmaceutical JSC Change In Receivables Historical Data

The historical data trend for ENLIE Pharmaceutical JSC's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENLIE Pharmaceutical JSC Change In Receivables Chart

ENLIE Pharmaceutical JSC Annual Data

Trend

Change In Receivables

ENLIE Pharmaceutical JSC Semi-Annual Data

Change In Receivables

ENLIE Pharmaceutical JSC Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

ENLIE Pharmaceutical JSC (HSTC:BCP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

ENLIE Pharmaceutical JSC's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=		/		*	91
=

2. In Ben Graham's calculation of liquidation value, ENLIE Pharmaceutical JSC's accounts receivable are only considered to be worth 75% of book value:

ENLIE Pharmaceutical JSC's liquidation value for the quarter that ended in . 20 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=		-		+	0.75 *	+	0.5 *
=	0.00

ENLIE Pharmaceutical JSC Change In Receivables Related Terms

Thank you for viewing the detailed overview of ENLIE Pharmaceutical JSC's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

ENLIE Pharmaceutical JSC (HSTC:BCP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ENLIE Pharmaceutical JSC (HSTC:BCP) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM

Website

http://www.enlie.vn

ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.

ENLIE Pharmaceutical JSC (HSTC:BCP) Headlines

No Headlines